Benzimidazole d-ribonucleosides inhibit DNA packaging during human cytomegalovirus (HCMV) replication. Although they have been shown to target pUL56 and pUL89 (the large and small subunits of the HCMV terminase, respectively) their mechanism of action is not yet fully understood. We aimed here to better understand HCMV DNA maturation and the mechanism of action of benzimidazole derivatives.
Methods
The HCMV pUL56 protein was studied by sequence analysis of the HCMV UL56 gene and herpesvirus counterparts combined with primary structure analysis of the corresponding amino acid sequences.
Results
The UL56 sequence analysis of 45 HCMV strains and counterparts among herpesviruses allowed the identification of 12 conserved regions. Moreover, comparison with the product of gene 49 (gp49) of bacteriophage T4 suggested that the pUL56 zinc finger is localized close to the dimerization site of pUL56, providing a spatial organization of the catalytic site that allows recognition and cleavage of DNA.
Conclusions
This study provides a basis to investigate the mechanism of concatemeric DNA cleavage and a biochemical basis for DNA packaging inhibition by benzimidazole derivatives.
References
1.
TownsendL.B., DevivarR., TurkS.R., NassiriM.R., DrachJ.C.Design, synthesis, and antiviral activity of certain 2,5,6-trihalo-1-(beta-d-ribofuranosyl)benzimidazoles.J Med Chem1995; 38: 4098–4105.
2.
WilliamsS., HartlineC.B., KushnerN.In vitro activities of benzimidazole d- and d-ribonucleosides against herpesviruses.Antimicrob Agents Chemother2003; 47: 2186–2192.
3.
ZimmermannA., WillsH., LenhardtM., HahnM., MertensT.Indolocarbazoles exhibit strong antiviral activity against human cytomegalovirus and are potent inhibitors of the pUL97 protein kinase.Antivir Res2000; 48: 49–60.
4.
UnderwoodM.L., HarveyR.J., StanatS.C.Inhibition of human cytomegalovirus DNA maturation by a benzimidazole ribonucleoside is mediated through the UL89 gene product.J Virol1998; 72: 717–725.
5.
KroskyP.M., BoryskoK.Z., NassiriM.R.Phosphorylation of beta-d-ribozyl benzimidazoles is not required for activity against human cytomegalovirus.Antimicrob Agents Chemother2002; 46: 478–486.
6.
KroskyP.M., UnderwoodM.L., TurkS.R.Resistance of human cytomegalovirus to benzimidazole ribonucleosides maps to two open reading frames: UL89 and UL56.J Virol1998; 72: 4721–4728.
7.
NixonD.E., McVoyM.A.Dramatic effects of 2-bromo-5,6-dichloro-1-beta-d-ribofuranosyl benzimidazole ribonucleoside on the genome structure, packaging, and egress of guinea pig cytomegalovirus.J Virol2004; 78: 1623–1635.
8.
KernE.R., HartlineC.B., RybakR.J.Activities of benzimidazole d- and l-ribonucleotides in animal models of cytomegalovirus infections.Antimicrob Agents Chemother2004; 48: 1749–1755.
9.
LalezariJ.P., AbergJ.A., WangL.H.Phase I dose escalation trial evaluating the pharmacokinetics, anti-human cytomegalovirus (HCMV) activity, and safety of 1263W94 in human immunodeficiency virus-infected men with asymptomatic HCMV shedding.Antimicrob Agents Chemother2002; 46: 2969–2976.
10.
MaJ.D., NafzigerA.N., VillanoS.A.Maribavir pharmacokinetics and the effects of multiple-dose maribavir on cytochrome P450 (CYP) 1A2, CYP 2C9, CYP 2C19, CYP 2D6, CYP3A, N-acetyltransferase-2, and xanthine oxidase activities in healthy adults.Antimicrob Agents Chemother2006; 50: 1130–1135.
11.
ChienT.C., SalujaS.S., DrachJ.C., TownsendL.B.Synthesis and evaluation of polyhalogenated imidazole nucleosides: dimensional analogues of 2,5,6-trichloro-1-(beta-d-ribofuranosyl) benzimidazole.J Med Chem2004; 47: 5743–5752.
12.
ChenJ., DrachJ.C., TownsendL.B.Convergent synthesis of polyhalogenated quinoline C-nucleosides as potential antiviral agents.J Org Chem2003; 68: 4170–4178.
13.
BognerE., RadsakK., StinskiM.F.The gene product of human cytomegalovirus open reading frame UL56 binds the pac motifs and has specific nuclease activity.J Virol1998; 72: 2259–2264.
14.
BuergerI., ReefschlaegerJ., BenderfW.A novel nucleoside inhibitor specifically targets cytomegalovirus DNA maturation via the UL89 and UL56 gene products.J Virol2001; 75: 9077–9086.
15.
BognerE.Human cytomegalovirus terminase as a target for antiviral chemotherapy.Rev Med Virol2002; 12: 115–127.
16.
ChampierG., HantzS., CouvreuxA.New functional domains of human cytomegalovirus pUL89 predicted by sequence analysis and three-dimensional modelling of the catalytic site DEXDc.Antivir Ther2007; 12: 217–232.
17.
KroskyP.M., PtakR.G., UnderwoodM.R., BironK.K., TownsendL.B., DrachJ.C.Difference in DNA packaging genes and sensitivity to benzimidazole ribonucleosides between human cytomegalovirus strains AD169 and Towne.Antivir Chem Chemother2000; 11: 349–352.
18.
ReefschlaegerJ., BenderfW., HallenbergerS.Novel non-nucleoside inhibitors of cytomegaloviruses (BAY38-4766): in vitro and in vivo antiviral activity and mechanism of action.J Antimicrob Chemother2001; 48: 757–767.
19.
SavvaC.G.W., HolzenburgA., BognerE.Insights into the structure of human cytomegalovirus large terminase subunit pUL56.FEBS Letters2004; 563: 135–140.
20.
HwangJ.S., BognerE.ATPase activity of the terminase subunit pUL56 of human cytomegalovirus.J Biol Chem2002; 277: 6943–6948.
21.
ScholzB., RechterS., DrachJ.C., TownsendL.B., BognerE.Identification of the ATP-binding site in the terminase subunit pUL56 of human cytomegalovirus.Nucleic Acids Res2003; 31: 1426–1433.
22.
GiesenK., RadsakK., BognerE.The potential terminase subunit pUL56 of HCMV is translocated into the nucleus by its own NLS and interacts with importin-alpha.J Gen Virol2000; 81: 2231–2244.
23.
ThomaC.B.E., MesserleM., RiegerM., HwangJ.S., BognerE.Identification of the interaction domain of the small terminase subunit pUL89 with the large subunit pUL56 of human cytomegalovirus.Biochemistry2006; 45: 8855–8863.
24.
DucancelleA.S., BellocA.S., AlainS.Comparison of sequential cytomegalovirus isolates in a patient with lymphoma and failing antiviral therapy.J Clin Virol2004; 29: 241–247.
25.
HirtB.Selective extraction of polyoma DNA from infected mouse cell culture.J Mol Biol1967; 26: 365–369.
26.
CheeM.S., BankierA.T., BeckS.Analysis of the protein-coding content of the sequence of human cytomegalovirus strain AD169.Curr Top Microbiol Immunol1990; 154: 125–169.
27.
ThompsonJ.D., HigginsD.G., GibsonT.J.CLUSTALW: improving the sensitivity of progressive multiple sequence alignment through sequence weighting, positions-specific gap penalties and weight matrix choice.Nucleic Acids Res1994; 22: 4673–4680.
28.
KingR.D., SternbergM.J.Identification and application of the concepts important for accurate and reliable protein secondary structure prediction.Protein Sci1996; 5: 2298–2310.
29.
GuermeurY., GeourjonC., GallinariP., DeléageG.Improved performance in protein secondary structure prediction by inhomogeneous score combination.Bioinformatics1999; 15: 413–421.
30.
RostB., SanderC.Conservation and prediction of solvent accessibility in protein families.Proteins1994; 20: 216–226.
31.
SchefficzikH., SavvaC.G., HolzenburgA.The terminase subunits pUL56 and pUL89 of human cytomegalovirus are DNA-metabolizing proteins with toroidal structure.Nucleic Acids Res2002; 30: 1695–1703.
32.
YamasakiK., KigawaT., InoueM.A novel zinc-binding motif revealed by solution structures of DNA-binding domains of arabidopsis SBP-family transcription factors.J Mol Biol2004; 337: 49–63.
33.
FilletA.M., AurayL., AlainS.Natural polymorphism of cytomegalovirus DNA polymerase lies in two nonconserved regions located between domains delta-C and II and between domains III and I.Antimicrob Agents Chemother2004; 48: 1865–1868.
34.
DittmerA., DrachJ.C., TownsendL.B., FischerA., BognerE.Interaction of the putative human cytomegalovirus portal protein pUL104 with the large terminase subunit pUL56 and its inhibition by benzimidazole-d-ribonucleosides.J Virol2005; 79: 14660–14667.
35.
KemperB., GarabettM.Studies on T4-head maturation. 1. Purification and characterization of gene-49-controlled endonuclease.Eur J Biochem1981; 115: 123–131.
36.
KemperB., JanzE.Function of gene 49 of bacteriophage T4. I. Isolation and biochemical characterization of very fast-sedimenting DNA.J Virol1976; 18: 992–999.
37.
MahdiA.A., SharplesG.J., MandalT.N., LloydR.G.Holliday junction resolvases encoded by rusA genes in Escherichia coli K-12 and Phage 82.J Mol Biol1996; 257: 561–573.
38.
StuartD., EllisonK., GrahamK., McFaddenG.In vitro resolution of poxvirus replicative intermediates into linear minichromosomes with hairpin termini by a virally induced Holliday junction endonuclease.J Virol1992; 66: 1551–1563.
39.
HollidayR.A mechanism for gene conversion in fungi.Genet Res1964; 5: 282–304.
40.
McCullochR., CogginsL.W., CollomsS.D., SherrattD.J.Xer-mediated site-specific recombination at cer generates Holliday junctions in vivo.EMBO J1994; 13: 1844–1855.
41.
McVoyM.A., RamnarainD.Machinery to support genome segment inversion exists in a herpesvirus which does not naturally contain invertible elements.J Virol2000; 74: 4882–4887.
42.
McVoyM.A., NixonD.E., HurJ.K., AdlerS.P., MocarskiE.S.Sequences within the herpesvirus-conserved pac1 and pac2 motifs are required for cleavage and packaging of the murine cytomegalovirus genome.J Virol1998; 72: 48–56.
43.
BirkenbihlR.P., KemperB.Localization and characterization of the dimerization domain of holliday structure resolving endonuclease VII of phage T4.J Mol Biol1998; 280: 73–83.
44.
PöhlerJ.R.G., Giraud-PanisM.J.E., LilleyD.M.J.T4 endonuclease VII selects and alters the structure of the four-way DNA junction; binding of a resolution-defective mutant enzyme.J Mol Biol1996; 260: 678–696.
45.
BirkenbihlR.P., KemperB.Endonuclease VII has two DNA-binding sites each composed from one N and one C terminus provided by different subunits of the protein dimer.EMBO J1998; 17: 4727–4734.
46.
TomaschewskiJ., RuegerW.Nucleotide sequence and primary structures of gene products coded for by T4 genome between map positions 48.266 kb and 39.266 kb.Nucleic Acids Res1987; 15: 3632–3633.
47.
Giraud-PanisM.J.E., DuckettD.R., LilleyD.M.J.The modular character of a DNA junction-resolving enzyme: a zinc-binding motif in bacteriophage T4 endonuclease VII.J Mol Biol1995; 252: 596–610.
48.
GolzS., ChristophA., Birkenkamp-DemtröderK., KemperB.Identification of amino acids of endonuclease VII essential for binding and cleavage of cruciform DNA.Eur J Biochem1997; 245: 573–580.
49.
RaaijmakersH., TöröI., BirkenbihlR.P., KemperB., SuckD.Conformational flexibility in T4 endonuclease VII revealed by crystallography: implications for substrate binding and cleavage.J Mol Biol2001; 308: 311–323.
50.
ManiM., SmithJ., KandavelouK., BergJ.M., ChandrasegaranS.Binding of two zinc finger nuclease monomers to two specific sites is required for effective double-strand DNA cleavage.Biochem Bioph Res Co2005; 334: 1191–1197.
51.
McVoyM.A., NixonD.E.Impact of 2-bromo-5,6-dichloro-1-beta-d-ribofuranosyl benzimidazole ribonucleoside and inhibitors of DNA, RNA, and protein synthesis on human cytomegalovirus maturation.J Virol2005; 79: 11115–11127.
52.
DuckettD.R., Giraud-PanisM.J.E., LilleyD.M.J.Binding of the junction resolving enzyme bacteriophage T7 endonuclease I to DNA: separation of binding and catalysis by mutation.J Mol Biol1995; 246: 95–107.
53.
Giraud-PanisM.J.E., LilleyD.M.J.T4 Endonuclease VII importance of a histidine-aspartate cluster within the zinc-binding domain.J Biol Chem1996; 51: 33148–33155.
54.
DolanA., CunninghamC., HectorR.D.Genetic content of wild-type human cytomegalovirus.J Gen Virol2004; 85: 1301–1312.
55.
DavisonA.J., DolanA., AkterP.The human cytomegalovirus genome revisited: comparison with the chimpanzee cytomegalovirus genome.J Gen Virol2003; 84: 17–28.
56.
MesserleM., KeilG.M., SchneiderK., KoszinowskiU.H.Characterization of the murine cytomegalovirus genes encoding the major DNA binding protein and the ICP18.5 homolog.Virology1992; 191: 355–367.
57.
BeukenE., SlobbeR., BruggemanC.A., VinkC.Cloning and sequence analysis of the genes encoding DNA polymerase, glycoprotein B, ICP18.5 and major DNA-binding protein of rat cytomegalovirus.J Gen Virol1996; 77: 1559–1562.
58.
DelhonG., MoraesM.P., LuZ.Genome of bovine herpesvirus 5.J Virol2003; 77: 10339–10347.
59.
BahrU., DaraiG.Analysis and characterization of the complete genome of tupaia (tree shrew) herpesvirus.J Virol2001; 75: 4854–4870.
60.
IsegawaY., MukaiT., NakanoK.Comparison of the complete DNA sequences of human herpesvirus 6 variants A and B.J Virol1999; 73: 8053–8063.
61.
KatoK., JangH.K., IzumiyaY.Identification of the Marek's disease virus serotype 2 genes homologous to the glycoprotein B (UL27), ICP18.5 (UL28) and major DNA-binding protein (UL29) genes of herpes simplex virus type 1.J Vet Med Sci1999; 61: 1161–1165.
62.
KinghamB.F., ZelníkV., KopácekJ., MajerciakV., NeyE., SchmidtC.J.The genome of herpesvirus of turkeys: comparative analysis with Marek's disease viruses.J Gen Virol2001; 82: 1123–1135.
63.
DolanA., McKieE., MacLeanA.R., McGeochD.J.Status of the ICP34.5 gene in herpes simplex virus type 1 strain 17.J Gen Virol1992; 73: 971–973.
64.
BarnettB.C., DolanA., TelfordE.A., DavisonA.J., McGeochD.J.A novel herpes simplex virus gene (UL49A) encodes a putative membrane protein with counterparts in other herpesviruses.J Gen Virol1992; 73: 2167–2171.
65.
PerelyginaL., ZhuL., ZurkuhlenH., MillsR., BorodovskyM., HilliardJ.K.Complete sequence and comparative analysis of the genome of herpes B virus (Cercopithecine herpesvirus 1) from a rhesus monkey.J Virol2003; 77: 6167–6177.
66.
TylerS.D., PetersG.A., SeveriniA.Complete genome sequence of cercopithecine herpesvirus 2 (SA8) and comparison with other simplex viruses.Virology2005; 331: 429–440.
67.
NigroO., Alonso AguirreA., LuY.Nucleotide sequence of an ICP18.5 assembly protein (UL28) gene of green turtle herpesvirus pathogenically associated with green turtle fibropapilloma.J Virol Methods2004; 120: 107–112.
68.
DavisonA.J., ScottJ.E.DNA sequence of the major capsid protein gene of herpes simplex virus type 1.J Gen Virol1986; 67: 2279–2286.
69.
KluppB.G., HengartnerC.J., MettenleiterT.C., EnquistL.W.Complete, annotated sequence of the pseudorabies virus genome.J Virol2004; 78: 424–440.
70.
MooreP.S., GaoS.J., DominguezG.Primary characterization of a herpesvirus agent associated with Kaposi's sarcomae.J Virol1996; 70: 549–558.
